Automated determination of human choriogonadotropin by use of microparticle capture analysis

1990 ◽  
Vol 36 (3) ◽  
pp. 554-556 ◽  
Author(s):  
D S Trundle ◽  
P P Chou ◽  
A Raymond
Keyword(s):  
Enzyme Immunoassay ◽  
Dynamic Range ◽  
High Dose ◽  
Hook Effect ◽  
Human Choriogonadotropin ◽  
Microparticle Enzyme Immunoassay ◽  
Automated Determination

Abstract We evaluated a new microparticle enzyme immunoassay (MEIA) for human choriogonadotropin (hCG) in serum. This hCG assay is fully automated for the Abbott "IMx System," which has a dynamic range extending to 100,000 int. units/L. We tested 321 patients' sera, with hCG values ranging between 0 and 196,000 int. units/L by both the IMx hCG (y) and the Hybritech Tandem-E hCG (x) assays. Results correlated well (r = 0.972, slope = 0.87, y-intercept = 0.7). The IMx hCG assay is sensitive (0.21 int. units/L) and precise (CVs 2.4-8.7% for various hCG concentrations). No carryover to subsequent specimens was observed when specimens with values up to 10(6) int. units/L were tested, nor was any high-dose "hook" effect noted. The IMx hCG assay, which is specific for intact hCG molecules, is rapid (one to six samples in 17 min) and is a valid automated alternative to enzymatic and radioisotopic methodologies.

scholarly journals Quantitative nephelometric assay for determining myoglobin evaluated

1990 ◽  
Vol 36 (9) ◽  
pp. 1675-1678 ◽  
Author(s):  
J R Delanghe ◽  
J P Chapelle ◽  
S C Vanderschueren
Keyword(s):  
Reliable Method ◽  
High Dose ◽  
Rheumatoid Factors ◽  
Test Results ◽  
Multiple Forms ◽  
Hook Effect ◽  
Tissue Extracts ◽  
The Mean ◽  
Serum Myoglobin

Abstract A recently introduced automated nephelometric immunoassay involving shell/core particles for determination of myoglobin (Behringwerke) was evaluated with the BNA Nephelometer. Method precision was good: the intra-assay CV varied between 1.5% and 6.1%; with daily calibration, the interassay CV ranged between 1.5% and 7.5%. For usual sample dilutions, the assay response varied linearly with myoglobin concentrations up to 23.1 nmol/L. After automatic dilution by the instrument, concentrations up to 2310 nmol/L could be measured without high-dose "hook" effect. Further manual dilution allowed measurement of myoglobin concentrations up to 26,000 nmol/L. Calibration was stable for at least seven days. We detected no significant interferences from hemoglobin, haptoglobin, bilirubin, iodine-containing contrast media, and rheumatoid factors. Treating lipemic samples with Lipoclean (Behringwerke) decreased test results. Simultaneously drawn serum and plasma samples from the same subject showed no consistent differences in myoglobin concentrations. The mean reference myoglobin concentration was 1.380 (SD 0.82) nmol/L for men and 0.878 (SD 0.45) nmol/L for women. In patients with renal insufficiency, serum creatinine values were moderately related to serum myoglobin values (r = 0.465). Although a commercial radioimmunoassay (Byk-Sangtec) and the nephelometric assay intercorrelated well (r = 0.929), values obtained by nephelometry were significantly lower (P less than 0.05). By both assays, results for heart and skeletal muscle tissue extracts showed no correlation, a finding that suggests the existence of multiple forms of myoglobin in human tissues. We conclude that immunonephelometry is a rapid, practical, and reliable method for measuring myoglobin in serum.

Rapid determination of serum myoglobin with a routine chemistry analyzer

1993 ◽  
Vol 39 (4) ◽  
pp. 653-658 ◽  
Author(s):  
A J Bakker ◽  
D A Boymans ◽  
D Dijkstra ◽  
J P Gorgels ◽  
R Lerk
Keyword(s):  
Predictive Value ◽  
Rapid Determination ◽  
Reference Interval ◽  
High Dose ◽  
Reference Limit ◽  
Hook Effect ◽  
Upper Limit ◽  
Upper Reference Limit ◽  
Serum Myoglobin

Abstract A turbidimetric immunoassay system (Turbitime system, Behringwerke AG) allows rapid determination of myoglobin in serum. We adapted the reagents for this myoglobin assay (Turbiquant myoglobin) for use with a Hitachi 717 analyzer. No high-dose hook effect was observed up to 15,000 micrograms/L. Interassay CVs were 4.6% (mean = 72.0 micrograms/L; n = 9) and 2.5% (mean = 365.6 micrograms/L; n = 11). The calibration curve was stable for at least 1 month. Hemolysis did not interfere, and turbidity from lipemia interfered only when absorbance exceeded 2.0 A. Results of this method (y) correlated well with those by the Turbitime method (y = 1.256x - 44.1 micrograms/L; n = 91; r = 0.991) and by a commercially available radioimmunoassay (Byk-Sangtec; y = 0.739x - 42.2 micrograms/L; n = 94; r = 0.991). The upper limit (95th percentile) of the reference interval for myoglobin was estimated at 57.9 micrograms/L. The positive predictive value for results of myoglobin at admission was 89% with this upper reference limit and 99% with 100 micrograms/L, whereas the negative predictive value was about 60% for both limits.

Recovery-test or immunoradiometric measurement of anti-thyroglobulinautoantibodies

2001 ◽  
Vol 40 (05) ◽  
pp. 155-163 ◽  
Author(s):  
G. Wunderlich ◽  
U. Liepach ◽  
R. Koch ◽  
J. Bredow ◽  
W.-G. Franke ◽  
...  
Keyword(s):  
Nuclear Medicine ◽  
Tumor Recurrence ◽  
High Dose ◽  
Immunoradiometric Assay ◽  
Clinical Value ◽  
Recovery Test ◽  
Metastatic Recurrence ◽  
Hook Effect

SummaryThe determination of thyroglobulin (Tg) in the follow-up of differentiated thyroid carcinomas (DTC), is routinely used in nuclear medicine, although some problems, like a disturbed recovery-test (RT) or autoantibodies to thyroglobulin (TgAb), are well known. But it is a controversial issue in literature, whether the determination of TgAb should be performed beside or instead of the RT. Objective: The study compares the clinical value of the determination of both TgAb and RT with sensitive assays. Methods: 356 patients (pts) were investigated. The results were compared to the concentration of Tg in the sera of the pts. 288 pts stayed tumor-free, the remaining 68 pts showed a recurrence (local and/or metastatic) of their DTC. We measured Tg (with RT) using an immunoradiometric assay (Tg-IRMA; SELco® Tg; Fa. Medipan Diagnostica GmbH) and TgAb using a direct assay (CentAK® anti-Tg; also from Fa. Medipan). Results: The prevalence of TgAb, and of disturbed RT respectively, in the whole population of DTC-pts was 7,6%, in the subgroup of tumor-free pts 6,6%, and in the remaining pts with tumor-recurrence 11,8%, respectively 2,0%, 1,7% and 2,9%. In a significantly higher percentage of pts with local/metastatic recurrence, both a positive TgAb (p <0,001) and a disturbed RT (p <0,05) were found. 7/68 pts with tumor-recurrence but Tg <1 ng/ml showed positive TgAb, only 2/7 had a disturbed RT. In this group, no patient with Tg >1 ng/ ml demonstrated either positive TgAb or disturbed RT (p <0,001 and p <0,05). Conclusion: The determination of TgAb in the follow-up of DTC is necessary, because it supports a suspicion to tumor-recurrence in pts with negative Tg. Also the RT is of great value because of a possibly High dose hook-effect.

scholarly journals Evaluation of Microparticle Enzyme Immunoassay (MEIA) Method for the Determination of Serum Dogoxin Concentration.

1997 ◽  
Vol 23 (5) ◽  
pp. 454-459
Author(s):  
NOBUYUKI SUGIOKA ◽  
KAZUYUKI YASUOKA ◽  
AKIRA UNO ◽  
KEIKO OKADA ◽  
HIKARU KOYAMA ◽  
...  
Keyword(s):  
Enzyme Immunoassay ◽  
Microparticle Enzyme Immunoassay
Sign in / Sign up

Export Citation Format

Share Document